What To Expect From Alzheimer's Drugmaker Biogen's Q4 Earnings On Wednesday?

Published on 11 Feb 2025 on Benzinga · via Yahoo Finance

January 2025 had been an eventful month for Biogen. Sage Therapeutics, Inc. (NASDAQ:SAGE) announced...

Read the rest of the article

Start tracking your investments with Statfolio

Rank & Stocks to Consider Sage Therapeutics currently carries a Zacks Rank #3 (Hold). Some...

Zacks · via Yahoo Finance 13 Feb 2025

Release Date: February 11, 2025 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 12 Feb 2025

January 2025 had been an eventful month for Biogen. Sage Therapeutics, Inc. (NASDAQ:SAGE) announc...

Benzinga · via Yahoo Finance 11 Feb 2025

Sage Therapeutics (SAGE) delivered earnings and revenue surprises of -7.59% and 11.20%,...

Zacks · via Yahoo Finance 11 Feb 2025

Sage Therapeutics (SAGE) witnessed a jump in share price last session on above-average trading...

Zacks · via Yahoo Finance 14 Jan 2025

U.S. stocks were mixed, with the Dow Jones index gaining over 200 points on Monday. Shares of Int...

Benzinga 13 Jan 2025

On Friday, Sage Therapeutics Inc. (NASDAQ:SAGE) confirmed that Biogen Inc. (NASDAQ:BIIB) submitte...

Benzinga · via Yahoo Finance 13 Jan 2025

Shares of Sage Therapeutics Inc. surged after Biogen Inc. offered to acquire the...

Bloomberg 13 Jan 2025

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for t...

The Business Journals 12 Jan 2025

, opens new tab that it does not already own for $7.22 apiece, a filing showed on Friday, sending...

Reuters 10 Jan 2025